Nykode Therapeutics Presents at the 41st Annual JP Morgan…
OSLO, Norway, December 23, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA NYKDa clinical-stage biopharmaceutical company devoted to the discovery and development of novel immunotherapies, today